Researchers from the Institute for Advanced Chemistry of Catalonia (IQAC) of the Spanish National Research Council (CSIC) ...
Most patients receiving a GLP-1 receptor agonist (RA) and a biologic continue co-therapy for over a year with few treatment-related adverse events.
Pyrroloquinoline quinone (PQQ) is a redox-active quinone that has garnered considerable attention for its diverse biological roles. Originally identified as a bacterial cofactor, PQQ has emerged as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results